Global Therapeutic Radioligands Market Research Report 2024(Status and Outlook)
Report Overview:
Therapeutic Radioligands is a type of targeted cancer therapy that combines the specificity of monoclonal antibodies with the destructive power of radiation. The treatment involves attaching radioactive isotopes to monoclonal antibodies, which are specialized proteins that can recognize and bind to specific antigens found on the surface of cancer cells.
The Global Therapeutic Radioligands Market Size was estimated at USD 1711.57 million in 2023 and is projected to reach USD 4481.29 million by 2029, exhibiting a CAGR of 17.40% during the forecast period.
This report provides a deep insight into the global Therapeutic Radioligands market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Therapeutic Radioligands Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Therapeutic Radioligands market in any manner.
Global Therapeutic Radioligands Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Bayer
Novartis
Lantheus
Aurobindo Pharma
Mundipharma
China Isotope & Radiation
Curium Pharmaceuticals
Gilead Sciences
Clarity Pharmaceuticals
Curasight
Nordic Nanovector
Philogen
RadioMedix
Telix Pharmaceuticals
Orano Med
Actinium Pharmaceuticals
Y-mAbs Therapeutics
Fusion Pharmaceuticals
Market Segmentation (by Type)
Beta-emitting
Targeted Alpha Therapy
Market Segmentation (by Application)
Solid Tumor
Non Hodgkin Lymphoma
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Therapeutic Radioligands Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Therapeutic Radioligands is a type of targeted cancer therapy that combines the specificity of monoclonal antibodies with the destructive power of radiation. The treatment involves attaching radioactive isotopes to monoclonal antibodies, which are specialized proteins that can recognize and bind to specific antigens found on the surface of cancer cells.
The Global Therapeutic Radioligands Market Size was estimated at USD 1711.57 million in 2023 and is projected to reach USD 4481.29 million by 2029, exhibiting a CAGR of 17.40% during the forecast period.
This report provides a deep insight into the global Therapeutic Radioligands market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Therapeutic Radioligands Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Therapeutic Radioligands market in any manner.
Global Therapeutic Radioligands Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Bayer
Novartis
Lantheus
Aurobindo Pharma
Mundipharma
China Isotope & Radiation
Curium Pharmaceuticals
Gilead Sciences
Clarity Pharmaceuticals
Curasight
Nordic Nanovector
Philogen
RadioMedix
Telix Pharmaceuticals
Orano Med
Actinium Pharmaceuticals
Y-mAbs Therapeutics
Fusion Pharmaceuticals
Market Segmentation (by Type)
Beta-emitting
Targeted Alpha Therapy
Market Segmentation (by Application)
Solid Tumor
Non Hodgkin Lymphoma
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Therapeutic Radioligands Market
- Overview of the regional outlook of the Therapeutic Radioligands Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Therapeutic Radioligands Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Therapeutic Radioligands
1.2 Key Market Segments
1.2.1 Therapeutic Radioligands Segment by Type
1.2.2 Therapeutic Radioligands Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 THERAPEUTIC RADIOLIGANDS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Therapeutic Radioligands Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Therapeutic Radioligands Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 THERAPEUTIC RADIOLIGANDS MARKET COMPETITIVE LANDSCAPE
3.1 Global Therapeutic Radioligands Sales by Manufacturers (2019-2024)
3.2 Global Therapeutic Radioligands Revenue Market Share by Manufacturers (2019-2024)
3.3 Therapeutic Radioligands Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Therapeutic Radioligands Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Therapeutic Radioligands Sales Sites, Area Served, Product Type
3.6 Therapeutic Radioligands Market Competitive Situation and Trends
3.6.1 Therapeutic Radioligands Market Concentration Rate
3.6.2 Global 5 and 10 Largest Therapeutic Radioligands Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 THERAPEUTIC RADIOLIGANDS INDUSTRY CHAIN ANALYSIS
4.1 Therapeutic Radioligands Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF THERAPEUTIC RADIOLIGANDS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 THERAPEUTIC RADIOLIGANDS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Therapeutic Radioligands Sales Market Share by Type (2019-2024)
6.3 Global Therapeutic Radioligands Market Size Market Share by Type (2019-2024)
6.4 Global Therapeutic Radioligands Price by Type (2019-2024)
7 THERAPEUTIC RADIOLIGANDS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Therapeutic Radioligands Market Sales by Application (2019-2024)
7.3 Global Therapeutic Radioligands Market Size (M USD) by Application (2019-2024)
7.4 Global Therapeutic Radioligands Sales Growth Rate by Application (2019-2024)
8 THERAPEUTIC RADIOLIGANDS MARKET SEGMENTATION BY REGION
8.1 Global Therapeutic Radioligands Sales by Region
8.1.1 Global Therapeutic Radioligands Sales by Region
8.1.2 Global Therapeutic Radioligands Sales Market Share by Region
8.2 North America
8.2.1 North America Therapeutic Radioligands Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Therapeutic Radioligands Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Therapeutic Radioligands Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Therapeutic Radioligands Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Therapeutic Radioligands Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Bayer
9.1.1 Bayer Therapeutic Radioligands Basic Information
9.1.2 Bayer Therapeutic Radioligands Product Overview
9.1.3 Bayer Therapeutic Radioligands Product Market Performance
9.1.4 Bayer Business Overview
9.1.5 Bayer Therapeutic Radioligands SWOT Analysis
9.1.6 Bayer Recent Developments
9.2 Novartis
9.2.1 Novartis Therapeutic Radioligands Basic Information
9.2.2 Novartis Therapeutic Radioligands Product Overview
9.2.3 Novartis Therapeutic Radioligands Product Market Performance
9.2.4 Novartis Business Overview
9.2.5 Novartis Therapeutic Radioligands SWOT Analysis
9.2.6 Novartis Recent Developments
9.3 Lantheus
9.3.1 Lantheus Therapeutic Radioligands Basic Information
9.3.2 Lantheus Therapeutic Radioligands Product Overview
9.3.3 Lantheus Therapeutic Radioligands Product Market Performance
9.3.4 Lantheus Therapeutic Radioligands SWOT Analysis
9.3.5 Lantheus Business Overview
9.3.6 Lantheus Recent Developments
9.4 Aurobindo Pharma
9.4.1 Aurobindo Pharma Therapeutic Radioligands Basic Information
9.4.2 Aurobindo Pharma Therapeutic Radioligands Product Overview
9.4.3 Aurobindo Pharma Therapeutic Radioligands Product Market Performance
9.4.4 Aurobindo Pharma Business Overview
9.4.5 Aurobindo Pharma Recent Developments
9.5 Mundipharma
9.5.1 Mundipharma Therapeutic Radioligands Basic Information
9.5.2 Mundipharma Therapeutic Radioligands Product Overview
9.5.3 Mundipharma Therapeutic Radioligands Product Market Performance
9.5.4 Mundipharma Business Overview
9.5.5 Mundipharma Recent Developments
9.6 China Isotope and Radiation
9.6.1 China Isotope and Radiation Therapeutic Radioligands Basic Information
9.6.2 China Isotope and Radiation Therapeutic Radioligands Product Overview
9.6.3 China Isotope and Radiation Therapeutic Radioligands Product Market Performance
9.6.4 China Isotope and Radiation Business Overview
9.6.5 China Isotope and Radiation Recent Developments
9.7 Curium Pharmaceuticals
9.7.1 Curium Pharmaceuticals Therapeutic Radioligands Basic Information
9.7.2 Curium Pharmaceuticals Therapeutic Radioligands Product Overview
9.7.3 Curium Pharmaceuticals Therapeutic Radioligands Product Market Performance
9.7.4 Curium Pharmaceuticals Business Overview
9.7.5 Curium Pharmaceuticals Recent Developments
9.8 Gilead Sciences
9.8.1 Gilead Sciences Therapeutic Radioligands Basic Information
9.8.2 Gilead Sciences Therapeutic Radioligands Product Overview
9.8.3 Gilead Sciences Therapeutic Radioligands Product Market Performance
9.8.4 Gilead Sciences Business Overview
9.8.5 Gilead Sciences Recent Developments
9.9 Clarity Pharmaceuticals
9.9.1 Clarity Pharmaceuticals Therapeutic Radioligands Basic Information
9.9.2 Clarity Pharmaceuticals Therapeutic Radioligands Product Overview
9.9.3 Clarity Pharmaceuticals Therapeutic Radioligands Product Market Performance
9.9.4 Clarity Pharmaceuticals Business Overview
9.9.5 Clarity Pharmaceuticals Recent Developments
9.10 Curasight
9.10.1 Curasight Therapeutic Radioligands Basic Information
9.10.2 Curasight Therapeutic Radioligands Product Overview
9.10.3 Curasight Therapeutic Radioligands Product Market Performance
9.10.4 Curasight Business Overview
9.10.5 Curasight Recent Developments
9.11 Nordic Nanovector
9.11.1 Nordic Nanovector Therapeutic Radioligands Basic Information
9.11.2 Nordic Nanovector Therapeutic Radioligands Product Overview
9.11.3 Nordic Nanovector Therapeutic Radioligands Product Market Performance
9.11.4 Nordic Nanovector Business Overview
9.11.5 Nordic Nanovector Recent Developments
9.12 Philogen
9.12.1 Philogen Therapeutic Radioligands Basic Information
9.12.2 Philogen Therapeutic Radioligands Product Overview
9.12.3 Philogen Therapeutic Radioligands Product Market Performance
9.12.4 Philogen Business Overview
9.12.5 Philogen Recent Developments
9.13 RadioMedix
9.13.1 RadioMedix Therapeutic Radioligands Basic Information
9.13.2 RadioMedix Therapeutic Radioligands Product Overview
9.13.3 RadioMedix Therapeutic Radioligands Product Market Performance
9.13.4 RadioMedix Business Overview
9.13.5 RadioMedix Recent Developments
9.14 Telix Pharmaceuticals
9.14.1 Telix Pharmaceuticals Therapeutic Radioligands Basic Information
9.14.2 Telix Pharmaceuticals Therapeutic Radioligands Product Overview
9.14.3 Telix Pharmaceuticals Therapeutic Radioligands Product Market Performance
9.14.4 Telix Pharmaceuticals Business Overview
9.14.5 Telix Pharmaceuticals Recent Developments
9.15 Orano Med
9.15.1 Orano Med Therapeutic Radioligands Basic Information
9.15.2 Orano Med Therapeutic Radioligands Product Overview
9.15.3 Orano Med Therapeutic Radioligands Product Market Performance
9.15.4 Orano Med Business Overview
9.15.5 Orano Med Recent Developments
9.16 Actinium Pharmaceuticals
9.16.1 Actinium Pharmaceuticals Therapeutic Radioligands Basic Information
9.16.2 Actinium Pharmaceuticals Therapeutic Radioligands Product Overview
9.16.3 Actinium Pharmaceuticals Therapeutic Radioligands Product Market Performance
9.16.4 Actinium Pharmaceuticals Business Overview
9.16.5 Actinium Pharmaceuticals Recent Developments
9.17 Y-mAbs Therapeutics
9.17.1 Y-mAbs Therapeutics Therapeutic Radioligands Basic Information
9.17.2 Y-mAbs Therapeutics Therapeutic Radioligands Product Overview
9.17.3 Y-mAbs Therapeutics Therapeutic Radioligands Product Market Performance
9.17.4 Y-mAbs Therapeutics Business Overview
9.17.5 Y-mAbs Therapeutics Recent Developments
9.18 Fusion Pharmaceuticals
9.18.1 Fusion Pharmaceuticals Therapeutic Radioligands Basic Information
9.18.2 Fusion Pharmaceuticals Therapeutic Radioligands Product Overview
9.18.3 Fusion Pharmaceuticals Therapeutic Radioligands Product Market Performance
9.18.4 Fusion Pharmaceuticals Business Overview
9.18.5 Fusion Pharmaceuticals Recent Developments
10 THERAPEUTIC RADIOLIGANDS MARKET FORECAST BY REGION
10.1 Global Therapeutic Radioligands Market Size Forecast
10.2 Global Therapeutic Radioligands Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Therapeutic Radioligands Market Size Forecast by Country
10.2.3 Asia Pacific Therapeutic Radioligands Market Size Forecast by Region
10.2.4 South America Therapeutic Radioligands Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Therapeutic Radioligands by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Therapeutic Radioligands Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Therapeutic Radioligands by Type (2025-2030)
11.1.2 Global Therapeutic Radioligands Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Therapeutic Radioligands by Type (2025-2030)
11.2 Global Therapeutic Radioligands Market Forecast by Application (2025-2030)
11.2.1 Global Therapeutic Radioligands Sales (Kilotons) Forecast by Application
11.2.2 Global Therapeutic Radioligands Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Therapeutic Radioligands
1.2 Key Market Segments
1.2.1 Therapeutic Radioligands Segment by Type
1.2.2 Therapeutic Radioligands Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 THERAPEUTIC RADIOLIGANDS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Therapeutic Radioligands Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Therapeutic Radioligands Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 THERAPEUTIC RADIOLIGANDS MARKET COMPETITIVE LANDSCAPE
3.1 Global Therapeutic Radioligands Sales by Manufacturers (2019-2024)
3.2 Global Therapeutic Radioligands Revenue Market Share by Manufacturers (2019-2024)
3.3 Therapeutic Radioligands Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Therapeutic Radioligands Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Therapeutic Radioligands Sales Sites, Area Served, Product Type
3.6 Therapeutic Radioligands Market Competitive Situation and Trends
3.6.1 Therapeutic Radioligands Market Concentration Rate
3.6.2 Global 5 and 10 Largest Therapeutic Radioligands Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 THERAPEUTIC RADIOLIGANDS INDUSTRY CHAIN ANALYSIS
4.1 Therapeutic Radioligands Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF THERAPEUTIC RADIOLIGANDS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 THERAPEUTIC RADIOLIGANDS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Therapeutic Radioligands Sales Market Share by Type (2019-2024)
6.3 Global Therapeutic Radioligands Market Size Market Share by Type (2019-2024)
6.4 Global Therapeutic Radioligands Price by Type (2019-2024)
7 THERAPEUTIC RADIOLIGANDS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Therapeutic Radioligands Market Sales by Application (2019-2024)
7.3 Global Therapeutic Radioligands Market Size (M USD) by Application (2019-2024)
7.4 Global Therapeutic Radioligands Sales Growth Rate by Application (2019-2024)
8 THERAPEUTIC RADIOLIGANDS MARKET SEGMENTATION BY REGION
8.1 Global Therapeutic Radioligands Sales by Region
8.1.1 Global Therapeutic Radioligands Sales by Region
8.1.2 Global Therapeutic Radioligands Sales Market Share by Region
8.2 North America
8.2.1 North America Therapeutic Radioligands Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Therapeutic Radioligands Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Therapeutic Radioligands Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Therapeutic Radioligands Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Therapeutic Radioligands Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Bayer
9.1.1 Bayer Therapeutic Radioligands Basic Information
9.1.2 Bayer Therapeutic Radioligands Product Overview
9.1.3 Bayer Therapeutic Radioligands Product Market Performance
9.1.4 Bayer Business Overview
9.1.5 Bayer Therapeutic Radioligands SWOT Analysis
9.1.6 Bayer Recent Developments
9.2 Novartis
9.2.1 Novartis Therapeutic Radioligands Basic Information
9.2.2 Novartis Therapeutic Radioligands Product Overview
9.2.3 Novartis Therapeutic Radioligands Product Market Performance
9.2.4 Novartis Business Overview
9.2.5 Novartis Therapeutic Radioligands SWOT Analysis
9.2.6 Novartis Recent Developments
9.3 Lantheus
9.3.1 Lantheus Therapeutic Radioligands Basic Information
9.3.2 Lantheus Therapeutic Radioligands Product Overview
9.3.3 Lantheus Therapeutic Radioligands Product Market Performance
9.3.4 Lantheus Therapeutic Radioligands SWOT Analysis
9.3.5 Lantheus Business Overview
9.3.6 Lantheus Recent Developments
9.4 Aurobindo Pharma
9.4.1 Aurobindo Pharma Therapeutic Radioligands Basic Information
9.4.2 Aurobindo Pharma Therapeutic Radioligands Product Overview
9.4.3 Aurobindo Pharma Therapeutic Radioligands Product Market Performance
9.4.4 Aurobindo Pharma Business Overview
9.4.5 Aurobindo Pharma Recent Developments
9.5 Mundipharma
9.5.1 Mundipharma Therapeutic Radioligands Basic Information
9.5.2 Mundipharma Therapeutic Radioligands Product Overview
9.5.3 Mundipharma Therapeutic Radioligands Product Market Performance
9.5.4 Mundipharma Business Overview
9.5.5 Mundipharma Recent Developments
9.6 China Isotope and Radiation
9.6.1 China Isotope and Radiation Therapeutic Radioligands Basic Information
9.6.2 China Isotope and Radiation Therapeutic Radioligands Product Overview
9.6.3 China Isotope and Radiation Therapeutic Radioligands Product Market Performance
9.6.4 China Isotope and Radiation Business Overview
9.6.5 China Isotope and Radiation Recent Developments
9.7 Curium Pharmaceuticals
9.7.1 Curium Pharmaceuticals Therapeutic Radioligands Basic Information
9.7.2 Curium Pharmaceuticals Therapeutic Radioligands Product Overview
9.7.3 Curium Pharmaceuticals Therapeutic Radioligands Product Market Performance
9.7.4 Curium Pharmaceuticals Business Overview
9.7.5 Curium Pharmaceuticals Recent Developments
9.8 Gilead Sciences
9.8.1 Gilead Sciences Therapeutic Radioligands Basic Information
9.8.2 Gilead Sciences Therapeutic Radioligands Product Overview
9.8.3 Gilead Sciences Therapeutic Radioligands Product Market Performance
9.8.4 Gilead Sciences Business Overview
9.8.5 Gilead Sciences Recent Developments
9.9 Clarity Pharmaceuticals
9.9.1 Clarity Pharmaceuticals Therapeutic Radioligands Basic Information
9.9.2 Clarity Pharmaceuticals Therapeutic Radioligands Product Overview
9.9.3 Clarity Pharmaceuticals Therapeutic Radioligands Product Market Performance
9.9.4 Clarity Pharmaceuticals Business Overview
9.9.5 Clarity Pharmaceuticals Recent Developments
9.10 Curasight
9.10.1 Curasight Therapeutic Radioligands Basic Information
9.10.2 Curasight Therapeutic Radioligands Product Overview
9.10.3 Curasight Therapeutic Radioligands Product Market Performance
9.10.4 Curasight Business Overview
9.10.5 Curasight Recent Developments
9.11 Nordic Nanovector
9.11.1 Nordic Nanovector Therapeutic Radioligands Basic Information
9.11.2 Nordic Nanovector Therapeutic Radioligands Product Overview
9.11.3 Nordic Nanovector Therapeutic Radioligands Product Market Performance
9.11.4 Nordic Nanovector Business Overview
9.11.5 Nordic Nanovector Recent Developments
9.12 Philogen
9.12.1 Philogen Therapeutic Radioligands Basic Information
9.12.2 Philogen Therapeutic Radioligands Product Overview
9.12.3 Philogen Therapeutic Radioligands Product Market Performance
9.12.4 Philogen Business Overview
9.12.5 Philogen Recent Developments
9.13 RadioMedix
9.13.1 RadioMedix Therapeutic Radioligands Basic Information
9.13.2 RadioMedix Therapeutic Radioligands Product Overview
9.13.3 RadioMedix Therapeutic Radioligands Product Market Performance
9.13.4 RadioMedix Business Overview
9.13.5 RadioMedix Recent Developments
9.14 Telix Pharmaceuticals
9.14.1 Telix Pharmaceuticals Therapeutic Radioligands Basic Information
9.14.2 Telix Pharmaceuticals Therapeutic Radioligands Product Overview
9.14.3 Telix Pharmaceuticals Therapeutic Radioligands Product Market Performance
9.14.4 Telix Pharmaceuticals Business Overview
9.14.5 Telix Pharmaceuticals Recent Developments
9.15 Orano Med
9.15.1 Orano Med Therapeutic Radioligands Basic Information
9.15.2 Orano Med Therapeutic Radioligands Product Overview
9.15.3 Orano Med Therapeutic Radioligands Product Market Performance
9.15.4 Orano Med Business Overview
9.15.5 Orano Med Recent Developments
9.16 Actinium Pharmaceuticals
9.16.1 Actinium Pharmaceuticals Therapeutic Radioligands Basic Information
9.16.2 Actinium Pharmaceuticals Therapeutic Radioligands Product Overview
9.16.3 Actinium Pharmaceuticals Therapeutic Radioligands Product Market Performance
9.16.4 Actinium Pharmaceuticals Business Overview
9.16.5 Actinium Pharmaceuticals Recent Developments
9.17 Y-mAbs Therapeutics
9.17.1 Y-mAbs Therapeutics Therapeutic Radioligands Basic Information
9.17.2 Y-mAbs Therapeutics Therapeutic Radioligands Product Overview
9.17.3 Y-mAbs Therapeutics Therapeutic Radioligands Product Market Performance
9.17.4 Y-mAbs Therapeutics Business Overview
9.17.5 Y-mAbs Therapeutics Recent Developments
9.18 Fusion Pharmaceuticals
9.18.1 Fusion Pharmaceuticals Therapeutic Radioligands Basic Information
9.18.2 Fusion Pharmaceuticals Therapeutic Radioligands Product Overview
9.18.3 Fusion Pharmaceuticals Therapeutic Radioligands Product Market Performance
9.18.4 Fusion Pharmaceuticals Business Overview
9.18.5 Fusion Pharmaceuticals Recent Developments
10 THERAPEUTIC RADIOLIGANDS MARKET FORECAST BY REGION
10.1 Global Therapeutic Radioligands Market Size Forecast
10.2 Global Therapeutic Radioligands Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Therapeutic Radioligands Market Size Forecast by Country
10.2.3 Asia Pacific Therapeutic Radioligands Market Size Forecast by Region
10.2.4 South America Therapeutic Radioligands Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Therapeutic Radioligands by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Therapeutic Radioligands Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Therapeutic Radioligands by Type (2025-2030)
11.1.2 Global Therapeutic Radioligands Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Therapeutic Radioligands by Type (2025-2030)
11.2 Global Therapeutic Radioligands Market Forecast by Application (2025-2030)
11.2.1 Global Therapeutic Radioligands Sales (Kilotons) Forecast by Application
11.2.2 Global Therapeutic Radioligands Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Therapeutic Radioligands Market Size Comparison by Region (M USD)
Table 5. Global Therapeutic Radioligands Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Therapeutic Radioligands Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Therapeutic Radioligands Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Therapeutic Radioligands Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Therapeutic Radioligands as of 2022)
Table 10. Global Market Therapeutic Radioligands Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Therapeutic Radioligands Sales Sites and Area Served
Table 12. Manufacturers Therapeutic Radioligands Product Type
Table 13. Global Therapeutic Radioligands Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Therapeutic Radioligands
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Therapeutic Radioligands Market Challenges
Table 22. Global Therapeutic Radioligands Sales by Type (Kilotons)
Table 23. Global Therapeutic Radioligands Market Size by Type (M USD)
Table 24. Global Therapeutic Radioligands Sales (Kilotons) by Type (2019-2024)
Table 25. Global Therapeutic Radioligands Sales Market Share by Type (2019-2024)
Table 26. Global Therapeutic Radioligands Market Size (M USD) by Type (2019-2024)
Table 27. Global Therapeutic Radioligands Market Size Share by Type (2019-2024)
Table 28. Global Therapeutic Radioligands Price (USD/Ton) by Type (2019-2024)
Table 29. Global Therapeutic Radioligands Sales (Kilotons) by Application
Table 30. Global Therapeutic Radioligands Market Size by Application
Table 31. Global Therapeutic Radioligands Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Therapeutic Radioligands Sales Market Share by Application (2019-2024)
Table 33. Global Therapeutic Radioligands Sales by Application (2019-2024) & (M USD)
Table 34. Global Therapeutic Radioligands Market Share by Application (2019-2024)
Table 35. Global Therapeutic Radioligands Sales Growth Rate by Application (2019-2024)
Table 36. Global Therapeutic Radioligands Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Therapeutic Radioligands Sales Market Share by Region (2019-2024)
Table 38. North America Therapeutic Radioligands Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Therapeutic Radioligands Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Therapeutic Radioligands Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Therapeutic Radioligands Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Therapeutic Radioligands Sales by Region (2019-2024) & (Kilotons)
Table 43. Bayer Therapeutic Radioligands Basic Information
Table 44. Bayer Therapeutic Radioligands Product Overview
Table 45. Bayer Therapeutic Radioligands Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Bayer Business Overview
Table 47. Bayer Therapeutic Radioligands SWOT Analysis
Table 48. Bayer Recent Developments
Table 49. Novartis Therapeutic Radioligands Basic Information
Table 50. Novartis Therapeutic Radioligands Product Overview
Table 51. Novartis Therapeutic Radioligands Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Novartis Business Overview
Table 53. Novartis Therapeutic Radioligands SWOT Analysis
Table 54. Novartis Recent Developments
Table 55. Lantheus Therapeutic Radioligands Basic Information
Table 56. Lantheus Therapeutic Radioligands Product Overview
Table 57. Lantheus Therapeutic Radioligands Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Lantheus Therapeutic Radioligands SWOT Analysis
Table 59. Lantheus Business Overview
Table 60. Lantheus Recent Developments
Table 61. Aurobindo Pharma Therapeutic Radioligands Basic Information
Table 62. Aurobindo Pharma Therapeutic Radioligands Product Overview
Table 63. Aurobindo Pharma Therapeutic Radioligands Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Aurobindo Pharma Business Overview
Table 65. Aurobindo Pharma Recent Developments
Table 66. Mundipharma Therapeutic Radioligands Basic Information
Table 67. Mundipharma Therapeutic Radioligands Product Overview
Table 68. Mundipharma Therapeutic Radioligands Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Mundipharma Business Overview
Table 70. Mundipharma Recent Developments
Table 71. China Isotope and Radiation Therapeutic Radioligands Basic Information
Table 72. China Isotope and Radiation Therapeutic Radioligands Product Overview
Table 73. China Isotope and Radiation Therapeutic Radioligands Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. China Isotope and Radiation Business Overview
Table 75. China Isotope and Radiation Recent Developments
Table 76. Curium Pharmaceuticals Therapeutic Radioligands Basic Information
Table 77. Curium Pharmaceuticals Therapeutic Radioligands Product Overview
Table 78. Curium Pharmaceuticals Therapeutic Radioligands Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Curium Pharmaceuticals Business Overview
Table 80. Curium Pharmaceuticals Recent Developments
Table 81. Gilead Sciences Therapeutic Radioligands Basic Information
Table 82. Gilead Sciences Therapeutic Radioligands Product Overview
Table 83. Gilead Sciences Therapeutic Radioligands Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Gilead Sciences Business Overview
Table 85. Gilead Sciences Recent Developments
Table 86. Clarity Pharmaceuticals Therapeutic Radioligands Basic Information
Table 87. Clarity Pharmaceuticals Therapeutic Radioligands Product Overview
Table 88. Clarity Pharmaceuticals Therapeutic Radioligands Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Clarity Pharmaceuticals Business Overview
Table 90. Clarity Pharmaceuticals Recent Developments
Table 91. Curasight Therapeutic Radioligands Basic Information
Table 92. Curasight Therapeutic Radioligands Product Overview
Table 93. Curasight Therapeutic Radioligands Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Curasight Business Overview
Table 95. Curasight Recent Developments
Table 96. Nordic Nanovector Therapeutic Radioligands Basic Information
Table 97. Nordic Nanovector Therapeutic Radioligands Product Overview
Table 98. Nordic Nanovector Therapeutic Radioligands Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Nordic Nanovector Business Overview
Table 100. Nordic Nanovector Recent Developments
Table 101. Philogen Therapeutic Radioligands Basic Information
Table 102. Philogen Therapeutic Radioligands Product Overview
Table 103. Philogen Therapeutic Radioligands Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Philogen Business Overview
Table 105. Philogen Recent Developments
Table 106. RadioMedix Therapeutic Radioligands Basic Information
Table 107. RadioMedix Therapeutic Radioligands Product Overview
Table 108. RadioMedix Therapeutic Radioligands Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. RadioMedix Business Overview
Table 110. RadioMedix Recent Developments
Table 111. Telix Pharmaceuticals Therapeutic Radioligands Basic Information
Table 112. Telix Pharmaceuticals Therapeutic Radioligands Product Overview
Table 113. Telix Pharmaceuticals Therapeutic Radioligands Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Telix Pharmaceuticals Business Overview
Table 115. Telix Pharmaceuticals Recent Developments
Table 116. Orano Med Therapeutic Radioligands Basic Information
Table 117. Orano Med Therapeutic Radioligands Product Overview
Table 118. Orano Med Therapeutic Radioligands Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. Orano Med Business Overview
Table 120. Orano Med Recent Developments
Table 121. Actinium Pharmaceuticals Therapeutic Radioligands Basic Information
Table 122. Actinium Pharmaceuticals Therapeutic Radioligands Product Overview
Table 123. Actinium Pharmaceuticals Therapeutic Radioligands Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 124. Actinium Pharmaceuticals Business Overview
Table 125. Actinium Pharmaceuticals Recent Developments
Table 126. Y-mAbs Therapeutics Therapeutic Radioligands Basic Information
Table 127. Y-mAbs Therapeutics Therapeutic Radioligands Product Overview
Table 128. Y-mAbs Therapeutics Therapeutic Radioligands Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 129. Y-mAbs Therapeutics Business Overview
Table 130. Y-mAbs Therapeutics Recent Developments
Table 131. Fusion Pharmaceuticals Therapeutic Radioligands Basic Information
Table 132. Fusion Pharmaceuticals Therapeutic Radioligands Product Overview
Table 133. Fusion Pharmaceuticals Therapeutic Radioligands Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 134. Fusion Pharmaceuticals Business Overview
Table 135. Fusion Pharmaceuticals Recent Developments
Table 136. Global Therapeutic Radioligands Sales Forecast by Region (2025-2030) & (Kilotons)
Table 137. Global Therapeutic Radioligands Market Size Forecast by Region (2025-2030) & (M USD)
Table 138. North America Therapeutic Radioligands Sales Forecast by Country (2025-2030) & (Kilotons)
Table 139. North America Therapeutic Radioligands Market Size Forecast by Country (2025-2030) & (M USD)
Table 140. Europe Therapeutic Radioligands Sales Forecast by Country (2025-2030) & (Kilotons)
Table 141. Europe Therapeutic Radioligands Market Size Forecast by Country (2025-2030) & (M USD)
Table 142. Asia Pacific Therapeutic Radioligands Sales Forecast by Region (2025-2030) & (Kilotons)
Table 143. Asia Pacific Therapeutic Radioligands Market Size Forecast by Region (2025-2030) & (M USD)
Table 144. South America Therapeutic Radioligands Sales Forecast by Country (2025-2030) & (Kilotons)
Table 145. South America Therapeutic Radioligands Market Size Forecast by Country (2025-2030) & (M USD)
Table 146. Middle East and Africa Therapeutic Radioligands Consumption Forecast by Country (2025-2030) & (Units)
Table 147. Middle East and Africa Therapeutic Radioligands Market Size Forecast by Country (2025-2030) & (M USD)
Table 148. Global Therapeutic Radioligands Sales Forecast by Type (2025-2030) & (Kilotons)
Table 149. Global Therapeutic Radioligands Market Size Forecast by Type (2025-2030) & (M USD)
Table 150. Global Therapeutic Radioligands Price Forecast by Type (2025-2030) & (USD/Ton)
Table 151. Global Therapeutic Radioligands Sales (Kilotons) Forecast by Application (2025-2030)
Table 152. Global Therapeutic Radioligands Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Therapeutic Radioligands Market Size Comparison by Region (M USD)
Table 5. Global Therapeutic Radioligands Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Therapeutic Radioligands Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Therapeutic Radioligands Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Therapeutic Radioligands Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Therapeutic Radioligands as of 2022)
Table 10. Global Market Therapeutic Radioligands Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Therapeutic Radioligands Sales Sites and Area Served
Table 12. Manufacturers Therapeutic Radioligands Product Type
Table 13. Global Therapeutic Radioligands Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Therapeutic Radioligands
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Therapeutic Radioligands Market Challenges
Table 22. Global Therapeutic Radioligands Sales by Type (Kilotons)
Table 23. Global Therapeutic Radioligands Market Size by Type (M USD)
Table 24. Global Therapeutic Radioligands Sales (Kilotons) by Type (2019-2024)
Table 25. Global Therapeutic Radioligands Sales Market Share by Type (2019-2024)
Table 26. Global Therapeutic Radioligands Market Size (M USD) by Type (2019-2024)
Table 27. Global Therapeutic Radioligands Market Size Share by Type (2019-2024)
Table 28. Global Therapeutic Radioligands Price (USD/Ton) by Type (2019-2024)
Table 29. Global Therapeutic Radioligands Sales (Kilotons) by Application
Table 30. Global Therapeutic Radioligands Market Size by Application
Table 31. Global Therapeutic Radioligands Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Therapeutic Radioligands Sales Market Share by Application (2019-2024)
Table 33. Global Therapeutic Radioligands Sales by Application (2019-2024) & (M USD)
Table 34. Global Therapeutic Radioligands Market Share by Application (2019-2024)
Table 35. Global Therapeutic Radioligands Sales Growth Rate by Application (2019-2024)
Table 36. Global Therapeutic Radioligands Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Therapeutic Radioligands Sales Market Share by Region (2019-2024)
Table 38. North America Therapeutic Radioligands Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Therapeutic Radioligands Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Therapeutic Radioligands Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Therapeutic Radioligands Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Therapeutic Radioligands Sales by Region (2019-2024) & (Kilotons)
Table 43. Bayer Therapeutic Radioligands Basic Information
Table 44. Bayer Therapeutic Radioligands Product Overview
Table 45. Bayer Therapeutic Radioligands Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Bayer Business Overview
Table 47. Bayer Therapeutic Radioligands SWOT Analysis
Table 48. Bayer Recent Developments
Table 49. Novartis Therapeutic Radioligands Basic Information
Table 50. Novartis Therapeutic Radioligands Product Overview
Table 51. Novartis Therapeutic Radioligands Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Novartis Business Overview
Table 53. Novartis Therapeutic Radioligands SWOT Analysis
Table 54. Novartis Recent Developments
Table 55. Lantheus Therapeutic Radioligands Basic Information
Table 56. Lantheus Therapeutic Radioligands Product Overview
Table 57. Lantheus Therapeutic Radioligands Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Lantheus Therapeutic Radioligands SWOT Analysis
Table 59. Lantheus Business Overview
Table 60. Lantheus Recent Developments
Table 61. Aurobindo Pharma Therapeutic Radioligands Basic Information
Table 62. Aurobindo Pharma Therapeutic Radioligands Product Overview
Table 63. Aurobindo Pharma Therapeutic Radioligands Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Aurobindo Pharma Business Overview
Table 65. Aurobindo Pharma Recent Developments
Table 66. Mundipharma Therapeutic Radioligands Basic Information
Table 67. Mundipharma Therapeutic Radioligands Product Overview
Table 68. Mundipharma Therapeutic Radioligands Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Mundipharma Business Overview
Table 70. Mundipharma Recent Developments
Table 71. China Isotope and Radiation Therapeutic Radioligands Basic Information
Table 72. China Isotope and Radiation Therapeutic Radioligands Product Overview
Table 73. China Isotope and Radiation Therapeutic Radioligands Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. China Isotope and Radiation Business Overview
Table 75. China Isotope and Radiation Recent Developments
Table 76. Curium Pharmaceuticals Therapeutic Radioligands Basic Information
Table 77. Curium Pharmaceuticals Therapeutic Radioligands Product Overview
Table 78. Curium Pharmaceuticals Therapeutic Radioligands Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Curium Pharmaceuticals Business Overview
Table 80. Curium Pharmaceuticals Recent Developments
Table 81. Gilead Sciences Therapeutic Radioligands Basic Information
Table 82. Gilead Sciences Therapeutic Radioligands Product Overview
Table 83. Gilead Sciences Therapeutic Radioligands Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Gilead Sciences Business Overview
Table 85. Gilead Sciences Recent Developments
Table 86. Clarity Pharmaceuticals Therapeutic Radioligands Basic Information
Table 87. Clarity Pharmaceuticals Therapeutic Radioligands Product Overview
Table 88. Clarity Pharmaceuticals Therapeutic Radioligands Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Clarity Pharmaceuticals Business Overview
Table 90. Clarity Pharmaceuticals Recent Developments
Table 91. Curasight Therapeutic Radioligands Basic Information
Table 92. Curasight Therapeutic Radioligands Product Overview
Table 93. Curasight Therapeutic Radioligands Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Curasight Business Overview
Table 95. Curasight Recent Developments
Table 96. Nordic Nanovector Therapeutic Radioligands Basic Information
Table 97. Nordic Nanovector Therapeutic Radioligands Product Overview
Table 98. Nordic Nanovector Therapeutic Radioligands Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Nordic Nanovector Business Overview
Table 100. Nordic Nanovector Recent Developments
Table 101. Philogen Therapeutic Radioligands Basic Information
Table 102. Philogen Therapeutic Radioligands Product Overview
Table 103. Philogen Therapeutic Radioligands Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Philogen Business Overview
Table 105. Philogen Recent Developments
Table 106. RadioMedix Therapeutic Radioligands Basic Information
Table 107. RadioMedix Therapeutic Radioligands Product Overview
Table 108. RadioMedix Therapeutic Radioligands Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. RadioMedix Business Overview
Table 110. RadioMedix Recent Developments
Table 111. Telix Pharmaceuticals Therapeutic Radioligands Basic Information
Table 112. Telix Pharmaceuticals Therapeutic Radioligands Product Overview
Table 113. Telix Pharmaceuticals Therapeutic Radioligands Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Telix Pharmaceuticals Business Overview
Table 115. Telix Pharmaceuticals Recent Developments
Table 116. Orano Med Therapeutic Radioligands Basic Information
Table 117. Orano Med Therapeutic Radioligands Product Overview
Table 118. Orano Med Therapeutic Radioligands Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. Orano Med Business Overview
Table 120. Orano Med Recent Developments
Table 121. Actinium Pharmaceuticals Therapeutic Radioligands Basic Information
Table 122. Actinium Pharmaceuticals Therapeutic Radioligands Product Overview
Table 123. Actinium Pharmaceuticals Therapeutic Radioligands Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 124. Actinium Pharmaceuticals Business Overview
Table 125. Actinium Pharmaceuticals Recent Developments
Table 126. Y-mAbs Therapeutics Therapeutic Radioligands Basic Information
Table 127. Y-mAbs Therapeutics Therapeutic Radioligands Product Overview
Table 128. Y-mAbs Therapeutics Therapeutic Radioligands Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 129. Y-mAbs Therapeutics Business Overview
Table 130. Y-mAbs Therapeutics Recent Developments
Table 131. Fusion Pharmaceuticals Therapeutic Radioligands Basic Information
Table 132. Fusion Pharmaceuticals Therapeutic Radioligands Product Overview
Table 133. Fusion Pharmaceuticals Therapeutic Radioligands Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 134. Fusion Pharmaceuticals Business Overview
Table 135. Fusion Pharmaceuticals Recent Developments
Table 136. Global Therapeutic Radioligands Sales Forecast by Region (2025-2030) & (Kilotons)
Table 137. Global Therapeutic Radioligands Market Size Forecast by Region (2025-2030) & (M USD)
Table 138. North America Therapeutic Radioligands Sales Forecast by Country (2025-2030) & (Kilotons)
Table 139. North America Therapeutic Radioligands Market Size Forecast by Country (2025-2030) & (M USD)
Table 140. Europe Therapeutic Radioligands Sales Forecast by Country (2025-2030) & (Kilotons)
Table 141. Europe Therapeutic Radioligands Market Size Forecast by Country (2025-2030) & (M USD)
Table 142. Asia Pacific Therapeutic Radioligands Sales Forecast by Region (2025-2030) & (Kilotons)
Table 143. Asia Pacific Therapeutic Radioligands Market Size Forecast by Region (2025-2030) & (M USD)
Table 144. South America Therapeutic Radioligands Sales Forecast by Country (2025-2030) & (Kilotons)
Table 145. South America Therapeutic Radioligands Market Size Forecast by Country (2025-2030) & (M USD)
Table 146. Middle East and Africa Therapeutic Radioligands Consumption Forecast by Country (2025-2030) & (Units)
Table 147. Middle East and Africa Therapeutic Radioligands Market Size Forecast by Country (2025-2030) & (M USD)
Table 148. Global Therapeutic Radioligands Sales Forecast by Type (2025-2030) & (Kilotons)
Table 149. Global Therapeutic Radioligands Market Size Forecast by Type (2025-2030) & (M USD)
Table 150. Global Therapeutic Radioligands Price Forecast by Type (2025-2030) & (USD/Ton)
Table 151. Global Therapeutic Radioligands Sales (Kilotons) Forecast by Application (2025-2030)
Table 152. Global Therapeutic Radioligands Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Therapeutic Radioligands
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Therapeutic Radioligands Market Size (M USD), 2019-2030
Figure 5. Global Therapeutic Radioligands Market Size (M USD) (2019-2030)
Figure 6. Global Therapeutic Radioligands Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Therapeutic Radioligands Market Size by Country (M USD)
Figure 11. Therapeutic Radioligands Sales Share by Manufacturers in 2023
Figure 12. Global Therapeutic Radioligands Revenue Share by Manufacturers in 2023
Figure 13. Therapeutic Radioligands Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Therapeutic Radioligands Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Therapeutic Radioligands Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Therapeutic Radioligands Market Share by Type
Figure 18. Sales Market Share of Therapeutic Radioligands by Type (2019-2024)
Figure 19. Sales Market Share of Therapeutic Radioligands by Type in 2023
Figure 20. Market Size Share of Therapeutic Radioligands by Type (2019-2024)
Figure 21. Market Size Market Share of Therapeutic Radioligands by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Therapeutic Radioligands Market Share by Application
Figure 24. Global Therapeutic Radioligands Sales Market Share by Application (2019-2024)
Figure 25. Global Therapeutic Radioligands Sales Market Share by Application in 2023
Figure 26. Global Therapeutic Radioligands Market Share by Application (2019-2024)
Figure 27. Global Therapeutic Radioligands Market Share by Application in 2023
Figure 28. Global Therapeutic Radioligands Sales Growth Rate by Application (2019-2024)
Figure 29. Global Therapeutic Radioligands Sales Market Share by Region (2019-2024)
Figure 30. North America Therapeutic Radioligands Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Therapeutic Radioligands Sales Market Share by Country in 2023
Figure 32. U.S. Therapeutic Radioligands Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Therapeutic Radioligands Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Therapeutic Radioligands Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Therapeutic Radioligands Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Therapeutic Radioligands Sales Market Share by Country in 2023
Figure 37. Germany Therapeutic Radioligands Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Therapeutic Radioligands Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Therapeutic Radioligands Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Therapeutic Radioligands Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Therapeutic Radioligands Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Therapeutic Radioligands Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Therapeutic Radioligands Sales Market Share by Region in 2023
Figure 44. China Therapeutic Radioligands Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Therapeutic Radioligands Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Therapeutic Radioligands Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Therapeutic Radioligands Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Therapeutic Radioligands Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Therapeutic Radioligands Sales and Growth Rate (Kilotons)
Figure 50. South America Therapeutic Radioligands Sales Market Share by Country in 2023
Figure 51. Brazil Therapeutic Radioligands Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Therapeutic Radioligands Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Therapeutic Radioligands Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Therapeutic Radioligands Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Therapeutic Radioligands Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Therapeutic Radioligands Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Therapeutic Radioligands Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Therapeutic Radioligands Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Therapeutic Radioligands Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Therapeutic Radioligands Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Therapeutic Radioligands Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Therapeutic Radioligands Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Therapeutic Radioligands Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Therapeutic Radioligands Market Share Forecast by Type (2025-2030)
Figure 65. Global Therapeutic Radioligands Sales Forecast by Application (2025-2030)
Figure 66. Global Therapeutic Radioligands Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Therapeutic Radioligands
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Therapeutic Radioligands Market Size (M USD), 2019-2030
Figure 5. Global Therapeutic Radioligands Market Size (M USD) (2019-2030)
Figure 6. Global Therapeutic Radioligands Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Therapeutic Radioligands Market Size by Country (M USD)
Figure 11. Therapeutic Radioligands Sales Share by Manufacturers in 2023
Figure 12. Global Therapeutic Radioligands Revenue Share by Manufacturers in 2023
Figure 13. Therapeutic Radioligands Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Therapeutic Radioligands Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Therapeutic Radioligands Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Therapeutic Radioligands Market Share by Type
Figure 18. Sales Market Share of Therapeutic Radioligands by Type (2019-2024)
Figure 19. Sales Market Share of Therapeutic Radioligands by Type in 2023
Figure 20. Market Size Share of Therapeutic Radioligands by Type (2019-2024)
Figure 21. Market Size Market Share of Therapeutic Radioligands by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Therapeutic Radioligands Market Share by Application
Figure 24. Global Therapeutic Radioligands Sales Market Share by Application (2019-2024)
Figure 25. Global Therapeutic Radioligands Sales Market Share by Application in 2023
Figure 26. Global Therapeutic Radioligands Market Share by Application (2019-2024)
Figure 27. Global Therapeutic Radioligands Market Share by Application in 2023
Figure 28. Global Therapeutic Radioligands Sales Growth Rate by Application (2019-2024)
Figure 29. Global Therapeutic Radioligands Sales Market Share by Region (2019-2024)
Figure 30. North America Therapeutic Radioligands Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Therapeutic Radioligands Sales Market Share by Country in 2023
Figure 32. U.S. Therapeutic Radioligands Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Therapeutic Radioligands Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Therapeutic Radioligands Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Therapeutic Radioligands Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Therapeutic Radioligands Sales Market Share by Country in 2023
Figure 37. Germany Therapeutic Radioligands Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Therapeutic Radioligands Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Therapeutic Radioligands Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Therapeutic Radioligands Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Therapeutic Radioligands Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Therapeutic Radioligands Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Therapeutic Radioligands Sales Market Share by Region in 2023
Figure 44. China Therapeutic Radioligands Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Therapeutic Radioligands Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Therapeutic Radioligands Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Therapeutic Radioligands Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Therapeutic Radioligands Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Therapeutic Radioligands Sales and Growth Rate (Kilotons)
Figure 50. South America Therapeutic Radioligands Sales Market Share by Country in 2023
Figure 51. Brazil Therapeutic Radioligands Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Therapeutic Radioligands Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Therapeutic Radioligands Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Therapeutic Radioligands Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Therapeutic Radioligands Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Therapeutic Radioligands Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Therapeutic Radioligands Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Therapeutic Radioligands Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Therapeutic Radioligands Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Therapeutic Radioligands Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Therapeutic Radioligands Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Therapeutic Radioligands Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Therapeutic Radioligands Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Therapeutic Radioligands Market Share Forecast by Type (2025-2030)
Figure 65. Global Therapeutic Radioligands Sales Forecast by Application (2025-2030)
Figure 66. Global Therapeutic Radioligands Market Share Forecast by Application (2025-2030)
